Role of centromere protein H and Ki67 in relapse-free survival of patients after primary surgery for hypopharyngeal cancer

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 3, 2012, Pages 821-825

  Wang, Jun Xi ^a   Zhang, Ying Yao ^a   Yu, Xue Min ^a   Jin, Tong ^a   Pan, Xin Liang ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Cell proliferation; Centromere protein H; Hypopharyngeal squamous cell carcinoma; Ki67; Survival

Indexed keywords

CENPH PROTEIN, HUMAN; CHOLECYSTOKININ OCTAPEPTIDE; KI 67 ANTIGEN; NONHISTONE PROTEIN; SMALL INTERFERING RNA;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL PROLIFERATION; DISEASE FREE SURVIVAL; FEMALE; FLOW CYTOMETRY; GENETICS; HUMAN; HYPOPHARYNX TUMOR; MALE; METABOLISM; MIDDLE AGED; RNA INTERFERENCE; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMOSOMAL PROTEINS, NON-HISTONE; DISEASE-FREE SURVIVAL; FEMALE; FLOW CYTOMETRY; HUMANS; HYPOPHARYNGEAL NEOPLASMS; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RNA INTERFERENCE; RNA, SMALL INTERFERING; SINCALIDE;

EID: 84871672823     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.3.821     Document Type: Article

References (31)

1. Bharadwaj R, Yu H (2004). The spindle checkpoint, aneuploidy, and cancer. Oncogene, 23, 2016-27.
2. Brenner H, Francisc Si, de Angelis R, et al (2009). Long-term survival expectations of cancer patients in Europe in 2000-2002. Eur J Cancer, 45, 1028-41.
3. Cleveland DW, Mao Y, Sullivan KF (2003). Centromeres and kinetochores: from epigenetics to mitotic checkpoint signaling. Cell, 112, 407-21.
4. Cooper JS, Porter K, Mallin K, et al (2009). National Cancer Database report on cancer of the head and neck: 10-year update. Head Neck, 31, 748-58.
5. Duesberg P, Li R (2003). Multistep carcinogenesis: a chain reaction of aneuploidizations. Cell Cycle, 2, 202-10.
6. Duesberg P, Rasnick D (2000). Aneuploidy, the somatic mutation that makes cancer a species of its own. Cell Motil Cytoskeleton, 47, 81-107.
7. Faratzis G, Tsiambas E, Rapidis AD, et al (2009). VEGF and ki 67 expression in squamous cell carcinoma of the tongue: An immunohistochemical and computerized image analysis study. Oral Oncol, 45, 584-8.
8. Fukagawa T, Mikmi Y, Nishihashi A (2000). CENP-H, a constitutive centromere component, is required for centromere targeting of CENP-C in verberate cells. EMBO J, 20, 4603-17.
9. Gerdes J, SchwabU, Lemke H, Stein H (1983). Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer, 31, 13-20.
10. Gourin CG, Terris DJ (2004). Carcinoma of the hypopharynx. Surg Oncol Clin N Am, 13, 81-98.
11. Guardia de la C, Casiano CA, Trinidad-Pinedo J, Baez A (2001). CENP-F gene amplification and overexpression in head and neck squamous cell carcinomas. Head Neck, 23, 104-12.
12. Guo XZ, Zhang G, Wang JY, et al (2008). Prognostic relevance of Centromere protein H expression in esophageal carcinoma. BMC Cancer, 8, 233.
13. Hanahan D, Weinberg RA (2000). The hallmarks of cancer. Cell, 100, 57-70.
14. Hoffman HT, Karnell LH, Funk GF, Robinson RA, Menck HR (1998). The National Cancer Data Base report on cancer of the head and neck. Arch Otolaryngol Head Neck Surg, 124, 951-62.
15. Hoffman HT, Karnell LH, ShahJP, et al (1997). Hypopharyngeal cancer patient care evaluation. Laryngoscope, 107, 1005-17.
16. Liao WT, Song LB, Zhang HZ, et al (2007). Centromere protein H is a novel prognostic marker for nasopharyngeal carcinoma progression and overall patient survival. Clin Cancer Res, 13, 508-14.
17. Liao WT, Wang X, Xu LH, et al (2009). Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival. Cancer, 115, 1507-17.
18. Martinez AC, van Wely KH (2011). Centromere fission, not telomere erosion, triggers chromosomal instability in human carcinomas. Carcinogenesis, 32, 796-803.
19. Mikami Y, Hori T, Kimura H, Fukagawa T (2005). The functional region of CENP-H interacts with the Nuf2 complex that locaises to centromere during mitosis. Mol Cell Bio, 25, 1958-70.
20. O'Brien SL, Fagan A, Fox EJ (2007). CENP-F expression is associated with poor prognosis and chromosomal instability in patients with primary breast cancer. Int J Cancer, 120, 1434-43.
21. Okada M, Cheeseman IM, Hori T, et al (2006). The CENP-H-I complex is required for the efficient incorporation of newly synthesized CENP-A into centromeres. Nat Cell Biol, 8, 446-57.
22. Orthaus S, Ohndorf S, Diekmann S (2006). RNAi knockdown of human kinetochore protein CENP-H. Biochem Biophys Res Commun, 348, 36-46.
23. Scholzen T, Gerdes J (2000). The Ki-67 protein: from the known and the unknown. J Cell Physiol, 182, 311-22.
24. Shigeishi H, Higashikawa K, Ono S, et al (2006). Increased expression of CENP-H gene in human oral squamous cell carcinomas harboring high-proliferative activity. Oncol Rep, 16, 1071-5.
25. Sugata N, Li S, Earnshaw WC, et al (2000). Human CENP-H multimers colocalize with CENP-A and CENP-C at active centromere-kinetochore complexes. Hum Mol Genet, 9, 2919-26.
26. Sugata N, Munekata E, Todokoro K (1999). Characterization of a novel kinetochore protein, CENP-H. J Biol Chem, 274, 27343-6.
27. Tomonaga T, Matsushita K, Ishibashi M, et al (2005). Centromere protein H is up-regulated in primary human colorectal cancer and its overexpression induces aneuploidy. Cancer Res, 65, 4683-9.
28. Tomonaga T, Matsushita K, Yamaguchi S (2003). Overexpression and mistargeting of centromere protein-A in human primary colorectal cancer. Cancer Res, 63, 3511-6.
29. van Diest PJ, BrugalG, Baak JP (1998). Proliferation markers in tumours:interpretation and clinical value. J Clin Pathol, 51, 716-24.
30. Wangsa D, Ryott M, Avall-Lundqvist E, et al (2008). Ki-67 expression predicts locoregional recurrence in stage I oral tongue carcinoma. Br J Cancer, 99, 1121-8.
31. Zhao X, Zhao L, Tian T (2010). Interruption of cenph causes mitotic failure and embryonic death, and its haploinsufficiency suppresses cancer in zebrafish. J Biol Chem, 285, 27924-34.